These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. How evolutionary crystal structure prediction works--and why. Oganov AR; Lyakhov AO; Valle M Acc Chem Res; 2011 Mar; 44(3):227-37. PubMed ID: 21361336 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure prediction and isostructurality of three small organic halogen compounds. Asmadi A; Kendrick J; Leusen FJ Phys Chem Chem Phys; 2010 Aug; 12(30):8571-9. PubMed ID: 20532368 [TBL] [Abstract][Full Text] [Related]
24. Crystal Structure Prediction via Efficient Sampling of the Potential Energy Surface. Wang Y; Lv J; Gao P; Ma Y Acc Chem Res; 2022 Aug; 55(15):2068-2076. PubMed ID: 35853142 [TBL] [Abstract][Full Text] [Related]
25. Is zeroth order crystal structure prediction (CSP_0) coming to maturity? What should we aim for in an ideal crystal structure prediction code? Price SL Faraday Discuss; 2018 Oct; 211(0):9-30. PubMed ID: 30051901 [TBL] [Abstract][Full Text] [Related]
26. Crystal Structure Prediction Methods for Organic Molecules: State of the Art. Bowskill DH; Sugden IJ; Konstantinopoulos S; Adjiman CS; Pantelides CC Annu Rev Chem Biomol Eng; 2021 Jun; 12():593-623. PubMed ID: 33770462 [TBL] [Abstract][Full Text] [Related]
27. Control and prediction of the organic solid state: a challenge to theory and experiment Price SL Proc Math Phys Eng Sci; 2018 Sep; 474(2217):20180351. PubMed ID: 30333710 [TBL] [Abstract][Full Text] [Related]
28. From crystal structure prediction to polymorph prediction: interpreting the crystal energy landscape. Price SL Phys Chem Chem Phys; 2008 Apr; 10(15):1996-2009. PubMed ID: 18688351 [TBL] [Abstract][Full Text] [Related]
29. The computational prediction of pharmaceutical crystal structures and polymorphism. Price SL Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583 [TBL] [Abstract][Full Text] [Related]
30. Recent progress of structural study of polymorphic pharmaceutical drugs. Higashi K; Ueda K; Moribe K Adv Drug Deliv Rev; 2017 Aug; 117():71-85. PubMed ID: 27940141 [TBL] [Abstract][Full Text] [Related]
31. Solid State Concerns During Drug Discovery and Development: Thermodynamic and Kinetic Aspects of Crystal Polymorphism and the Special Cases of Concomitant Polymorphs, Co-Crystals and Glasses. Otto DP; De Villiers MM Curr Drug Discov Technol; 2017; 14(2):72-105. PubMed ID: 27908255 [TBL] [Abstract][Full Text] [Related]
32. Solvothermal synthesis of perovskites and pyrochlores: crystallisation of functional oxides under mild conditions. Modeshia DR; Walton RI Chem Soc Rev; 2010 Nov; 39(11):4303-25. PubMed ID: 20532260 [TBL] [Abstract][Full Text] [Related]